Virtual Science Writers Conference will examine obesity treatments and heart health

The advent of new anti-obesity medications is changing the obesity treatment landscape.

Endocrine Society experts will discuss how these medications and bariatric surgery can treat obesity and improve cardiometabolic health, during the Society’s Virtual Science Writers Conference on November 9.

What: The Virtual Science Writers Conference will examine:

• How a new generation of anti-obesity medications, including semaglutide and tirzepatide, may benefit cardiometabolic health
• Bariatric surgery’s place in the evolving obesity treatment landscape

Who:

• Srividya Kidambi, M.D., M.S., of the Medical College of Wisconsin in Milwaukee, Wis.
• Jaime Almandoz, M.D., M.B.A., of UT Southwestern Medical Center in Dallas, Texas.
• Endocrine Society Chief Medical Officer Robert W. Lash, M.D.

When: Thursday, Nov. 9 at 1 PM Eastern

Register to attend the virtual Science Writers Conference by emailing [email protected]. Registered reporters will receive log-in details.

Priority will be given to journalists seeking to register. The recording of this event will be made available on the Society’s YouTube channel for other audiences.

About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers. The Endocrine Society is the largest global organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

With more than 18,000 members in 133 countries, the Society serves as the voice of the endocrine field. Through its renowned journals and ENDO, the world's largest endocrine meeting, the Society accelerates hormone research, advances clinical excellence in endocrinology, and advocates for evidence-based policies on behalf of the global endocrine community. To learn more, visit our online newsroom.